NCT05967455View on ClinicalTrials.gov

Homologous Re-infection With Dengue 1 or Dengue 3

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

August 26, 2024

Study Completion Date

August 26, 2024

Conditions
Dengue
Interventions
BIOLOGICAL

Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)

Dengue subtype 1 Challenge Virus (DENV-1) strain 45AZ5

BIOLOGICAL

Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)

Dengue subtype 3 Challenge Virus (DENV-3) strain CH53489

Trial Locations (1)

13210

State University of New York, Upstate Medical University (SUNY-UMU), Syracuse

All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

State University of New York - Upstate Medical University

OTHER

NCT05967455 - Homologous Re-infection With Dengue 1 or Dengue 3 | Biotech Hunter | Biotech Hunter